Valuation : Virbac

Market Cap 2.67B 3.11B 2.51B 2.3B 4.3B 293B 4.31B 29.71B 11.53B 150B 11.66B 11.41B 485B P/E 2026 *
15.7x
P/E 2027 * 14.2x
Enterprise Value 2.8B 3.25B 2.63B 2.41B 4.5B 307B 4.51B 31.12B 12.08B 158B 12.22B 11.95B 508B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.67x
Free-Float
49.03%
Yield 2026 *
0.54%
Yield 2027 * 0.64%
1 day-6.07%
3 months-6.07%
6 months-12.16%
Current year-12.16%
Current year 382.75
Extreme 382.75
413.75
1 year 382.75
Extreme 382.75
436.32
3 years 288
Extreme 288
436.32
5 years 288
Extreme 288
436.32
10 years 131
Extreme 131
436.32
Manager TitleAgeSince
Chief Executive Officer 46 31/08/2025
Chief Executive Officer 50 26/09/2024
Chief Operating Officer 64 31/12/2021
Director TitleAgeSince
Chairman 61 31/03/2006
Director/Board Member 68 27/07/2010
Director/Board Member 65 04/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-6.07%-.--% - - 3.11B
-0.63%-1.98%-50.55%-59.43% 31.33B
+0.33%+1.62%+32.94%+104.68% 12.24B
+3.00%-2.83%-12.37%+3.50% 3.93B
-0.62%-1.39%-1.54%+18.37% 3.11B
-0.16%-2.84%+50.55%+30.99% 2B
-1.01%-4.06%+12.59%+9.08% 1.89B
-0.86%+1.54%-3.04%+196.28% 1.55B
+2.49%+2.25%-18.22%-4.02% 1.2B
+2.53%+0.15%-7.26%-40.77% 1.05B
Average -0.10%-0.48%+0.34%+28.74% 6.48B
Weighted average by Cap. -0.37%-0.97%-19.61%-2.97%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.46B 1.33B 2.49B 170B 2.5B 17.24B 6.69B 87.31B 6.77B 6.62B 281B 1.65B 1.91B 1.55B 1.42B 2.65B 181B 2.66B 18.31B 7.11B 92.73B 7.19B 7.03B 299B
Net income 171M 199M 161M 147M 275M 18.78B 276M 1.9B 738M 9.63B 747M 730M 31.03B 190M 220M 178M 163M 305M 20.8B 306M 2.11B 818M 10.67B 827M 809M 34.38B
Net Debt 127M 147M 119M 109M 204M 13.91B 204M 1.41B 547M 7.14B 553M 541M 22.99B 75.16M 87.34M 70.71M 64.6M 121M 8.25B 121M 836M 324M 4.23B 328M 321M 13.63B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
319.00EUR
Average target price
411.88EUR
Spread / Average Target
+29.11%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!